“Limit risks for the patient”

Luca Augsburger and his partner, Rafik Ouared, started StrokeLab in September 2008 to facilitate the treatment of brain aneurysms.

Luca21.jpg
Luca Augsburger

Often discovered by chance in visits to the doctor, asymptomatic aneurysms affect 2-4% of the Swiss population. Even so, more than nine cases out of ten are treated unnecessarily because the aneurysm would not have had any consequences for the patient. “Treatment involves assumption of superfluous risk for the patient and considerable cost to the health system,” notes Luc Augsburger.

Following a degree in electrical engineering in 2003, a master’s degree in biomedical engineering and a thesis on cerebral aneurysms, which led him to work in a Geneva hospital, the 30-year-old entrepreneur launched the StrokeLab project in 2008 with his partner Rafik Ouared. “In my contacts with the hospital environment, I realized that doctors depend on engineers, particularly for modeling.” In order to develop his company, Augsburger enrolled in the venture challenge program in 2009.
 
Rewarded for the two first venture kick stages with 30,000 Swiss francs in financing, StrokeLab provides complementary information to doctors confronted with aneurysm cases. Based on a numerical simulation of blood flow and associated with a morphological analysis of the patient and his/her pathology, this technique contributes to the medical diagnosis, without taking its place. “It’s always a delicate operation, particularly in cases where metal filaments are inserted in the weakened areas of an artery.”
 
The calculations of blood flow volumes, and pressure and friction analyses associated with each aneurysm profile also allow StrokeLab to evaluate the effectiveness of various different treatment methods in a personalized way.

Weiterführende Links

annual report 2013

Mehr als 11 Mio. an Startkapital, über 298 finanzierte Startups, mehr als 464 Mio. an Folgefinanzierungen und 2433 neue Jobs - dies ist der Erfolgsausweis von venture kick seit die private Initiative im Herbst 2007 ins Leben gerufen wurde (Konsortium).

annual report 2013

Eine philanthropische Initiative eines privaten Konsortiums

Wissenschaftliche Innovationen in die Marktwirtschaft zu transferieren und damit nachhaltige Arbeitsplätze zu schaffen ist der Schlüssel für sozialen und wirtschaftlichen Wohlstand. Startups sind besonders in den Anfängen hohen wirtschaftlichen Risiken ausgesetzt, die weder von öffentlichen Geldern, noch von privaten Investoren abgefedert werden. Diese Lücke zu schliessen und Startups in einer sehr frühen Phase zu unterstützen ist wichtig und eine philantropische Aufgabe.